An isolated hypogonadotropic hypogonadism male with a novel de novo <i>FGFR1</i> mutation fathered a normal son evidenced by prenatal genetic diagnosis
Hao Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jihong Liu(Tongji Hospital), Yinwei Chen(Tongji Hospital), Tao Wang(Tongji Hospital), Shaogang Wang(Tongji Hospital), Daoqi Wang(The University of Texas MD Anderson Cancer Center), Zongzhe Li(Tongji Hospital), Taotao Sun(First Affiliated Hospital of Zhengzhou University)
Cited by 1
Related Papers
ATR Inhibition Induces CDK1–SPOP Signaling and Enhances Anti–PD-L1 Cytotoxicity in Prostate Cancer
|Clinical Cancer Research|2021|145
A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinoma
|BMC Cancer|2022|97
Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study
|The Lancet Oncology|2019|95
Liraglutide Ameliorates Erectile Dysfunction via Regulating Oxidative Stress, the RhoA/ROCK Pathway and Autophagy in Diabetes Mellitus
|Frontiers in Pharmacology|2020|95